Erratum: The prognostic significance of fragile X mental retardation syndrome-related protein 1 (FXR1) in breast cancer
Erratum to: Transl Cancer Res 2025;14:980-9.
In the published article entitled “The prognostic significance of fragile X mental retardation syndrome-related protein 1 (FXR1) in breast cancer” (Transl Cancer Res 2025;14:980-9; doi: 10.21037/tcr-24-1542) (1), the use of the term “retardation” in the title and content of the manuscript may be considered outdated. According to current naming conventions and based on the reader’s feedback, the gene is now referred to as “FMR1 autosomal homolog 1”, rather than “fragile X mental retardation, autosomal homolog 1”.
The authors apologize for any inconvenience that it may have caused.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Alsalmi OA, Aljohani AI, Alharthi AA, et al. The prognostic significance of fragile X mental retardation syndrome-related protein 1 (FXR1) in breast cancer. Transl Cancer Res 2025;14:980-9. [Crossref] [PubMed]
